![](/img/cover-not-exists.png)
Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
Miguel ArguedasVolume:
22
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-200422070-00005
Date:
May, 2004
File:
PDF, 59 KB
english, 2004